<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: NOVASTRALIST HORIZON LTD -->
          <cik>0002149739</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Class A Ordinary Shares, par value US$0.001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>08/18/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001837821</issuerCik>
        <issuerName>Jin Medical International Ltd.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>G5140V120</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>No. 33 Lingxiang Road, Wujin District</com:street1>
          <com:city>Changzhou City</com:city>
          <com:stateOrCountry>F4</com:stateOrCountry>
          <com:zipCode>213149</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>NOVASTRALIST HORIZON LTD.</reportingPersonName>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>7702376.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>7702376.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7702376.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>10.46</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>The numbers in Rows 5, 7, and 9 consist of 7,702,376 Class A ordinary shares of JIN MEDICAL INTERNATIONAL LTD.  (the "Issuer") held by NovastraList Horizon LTD.  The percentage in Row 11 is calculated based on a total of 73,663,428 Class A ordinary shares outstanding as of July 28, 2026, as provided by the Issuer.  Chang Gil LEE is the sole director and 100% owner of NovastraList Horizon LTD. and exercises voting and dispositive power over the Class A Ordinary Shares held by NovastraList Horizon LTD.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Chang Gil LEE</reportingPersonName>
      <citizenshipOrOrganization>M5</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>7702376.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>7702376.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>7702376.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>10.46</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>The numbers in Rows 5, 7, and 9 consist of 7,702,376 Class A ordinary shares of JIN MEDICAL INTERNATIONAL LTD.  (the "Issuer") held by NovastraList Horizon LTD.  The percentage in Row 11 is calculated based on a total of 73,663,428 Class A ordinary shares outstanding as of July 28, 2026, as provided by the Issuer.

Chang Gil LEE is the sole director and 100% owner of NovastraList Horizon LTD. Chang Gil LEE has dispositive and voting power with respect to, and as such, may be deemed to be the beneficial owner of the securities held by NovastraList Horizon LTD.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Jin Medical International Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, 213149, People's Republic of China</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>NovastraList Horizon LTD.
Chang Gil LEE

The Class A ordinary shares reported herein are directly held by NovastraList Horizon LTD. Chang Gil LEE is the sole shareholder of NovastraList Horizon LTD. Accordingly, Chang Gil LEE may be deemed to indirectly beneficially own the Class A ordinary shares of the Issuer held by NovastraList Horizon LTD. Chang Gil LEEdisclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>NovastraList Horizon LTD. : 410, YK First Tower, 565 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Korea, Republic of

Chang Gil LEE: 410, YK First Tower, 565 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do, Korea, Republic of</principalBusinessOfficeOrResidenceAddress>
        <citizenship>NovastraList Horizon LTD.: British Virgin Islands

Chang Gil LEE: South Korea</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>7,702,376 Class A Ordinary Shares</amountBeneficiallyOwned>
        <classPercent>10.46%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>7,702,376 Class A Ordinary Shares</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>7,702,376 Class A Ordinary Shares</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <exhibitInfo>99.1 Joint Filing Agreement</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>NOVASTRALIST HORIZON LTD.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Chang Gil LEE</signature>
        <title>Chang Gil LEE, Director of NovastraList Horizon LTD.</title>
        <date>08/18/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Chang Gil LEE</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Chang Gil LEE</signature>
        <title>Chang Gil LEE</title>
        <date>08/18/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
